Growing Healthy Places: Mississauga to support children’s health and well-being across the city 2025.03.20

Health Canada approves Wegovy® (semaglutide injection) to reduce the risk of non-fatal myocardial infarction 2024.11.27
Léger survey shows four out of five Quebecers call for greater support for obesity from the government and public health system 2024.10.21
Awiqli® – world’s first once-weekly basal insulin–now available in Canada 2024.06.17
Wegovy® (semaglutide injection) available in Canada 2024.05.02

Novo Nordisk to acquire Inversago Pharma to develop new therapies for people living with obesity, diabetes and other serious metabolic diseases 2023.08.10
Aspect Biosystems and Novo Nordisk enter partnership to develop bioprinted tissue therapeutics for diabetes and obesity 2023.04.12

Creation of a National Training Program for Healthcare Professionals Involved in Obesity Prevention and Care 2022.04.05

Continued Support for Banting and Best’s Insulin Discovery and Research at the University of Toronto
 2021.04.12
Novo Nordisk and the University of Toronto announce joint 200 DKK million investment to address diabetes and chronic disease prevention  2021.02.24

Camp Huronda receives $1.5M donation to rebuild on-site medical centre

  2021.01.14
Camp Huronda infographic                                                                                                                                                     2021.01.14